Release of Guidelines for Early Detection of Prostate Cancer

This week saw the release of the new national guidelines for the early detection of prostate cancer in Australia. Developed by PCFA in partnership with peak bodies, experts, and consumers, and endorsed by USANZ, they replace the 2016 Guidelines and establish a new national framework for risk assessment, individualised PSA testing, and contemporary pathways for diagnostic care.

The Guidelines represents a significant advance in prostate cancer policy. Australia has become one of the first countries in the world to move from an informal model of discretionary testing to a planned, evidence-based approach to opportunistic early detection.

Key changes include:

• A risk-based framework, with higher-risk status extended to men with a confirmed BRCA2 mutation and Black males of sub-Saharan African ancestry, alongside significant family history.
• Biennial PSA testing offered to males aged 50–69 following informed discussion, with referral for further investigation at a confirmed total PSA of 3.0 µg/L or greater; testing from age 45 for higher-risk males, at lower referral thresholds.
• Multiparametric MRI recommended before biopsy, with targeted plus systematic transperineal biopsy the preferred technique
• Active surveillance for low-risk disease and selected intermediate-risk disease, with defined eligibility criteria and monitoring protocols.

The Steering Committee examined more than 27,000 scientific abstracts, evaluated more than 1,100 published research papers, and considered more than 1,400 submissions received through three rounds of public consultation.

The Hon Mark Butler MP (Minister for Health and Ageing, Minister for Disability and the National Disability Insurance Scheme) issued a press release, emphasising that the new guidelines "aim to support earlier detection, by focusing on each person’s risk of developing prostate cancer, while reducing the potential harms caused by overdiagnosis and overtreatment."

For more information and to download the new Guidelines, visit the PCFA website. The website includes the full guidelines, technical reports

USANZ Members may also be interested in infographic developed by the PCFA. This provides a plain-language summary on a single A4 page, which could be displayed in waiting rooms or shared with patients. You can also order printed copies by emailing PCFA.